The United States’ lead is shrinking in the race to extend human life.
Nature Index |
The biomedical sciences have helped global average life expectancy rise by 20 years since 1960. This supplement highlights scientists and institutions prominent in the ongoing research effort that will further transform our ideals of a healthy human life in the coming decades.
Features and comment
Ethical and equity challenges become more urgent.
From antibiotics and organoids to CRISPR, improved biomedical methods and apparatus are enabling new therapies.
At the Estonian Genome Centre, the geneticist and her team are investigating the impact of genetic variations on drug metabolism and adherence to prescriptions.
Corporate research in the life sciences endures, despite diminishing in other fields of science.
This scientific partnership could fight everything from blood diseases to HIV.
A description of the terminology and methodology used in this supplement, and a guide to the functionality available free online at natureindex.com.
From neuroscience, to cancer biology, and regenerative medicine, exploration by biomedical scientists at City University of Hong Kong is searching for therapies for major global diseases.
Indiana's flagship university is developing regenerative medicine treatments that could transform how doctors repair human tissue—and perhaps even organs.
A premium cancer centre in China, Sun Yat-sen University Cancer Center is looking for talented researchers to join its mission of improving cancer diagnosis and treatment, and promoting technological advancement.
The hospital which brought Western medicine to China is poised to become a world-class comprehensive research hospital, and is looking for talented researchers to join its endeavour.
Two leading Dutch institutions are joining forces to create the country’s first technical university medical centre to transform health.
A hospital in West China is among the nation’s leaders due to its strong investment in research platforms and talents, and translation into clinical application.
Q-Gen Cell Therapeutics has been manufacturing cellular immunotherapies for decades and is now taking those treatments to patients around the world.